EP Patent

EP0290922B1 — Teicoplanin derivatives

Assigned to Gruppo Lepetit SpA · Expires 1993-11-10 · 33y expired

What this patent protects

The present invention is directed to new antibiotic substances which are 34-de-(acetylaminoglucopyranosyl)-34-deoxy teicoplanin derivatives (I) possessing antimicrobial activity in particular against gram positive bacteria. <CHEM> wherein A represents hydrogen or OA re…

USPTO Abstract

The present invention is directed to new antibiotic substances which are 34-de-(acetylaminoglucopyranosyl)-34-deoxy teicoplanin derivatives (I) possessing antimicrobial activity in particular against gram positive bacteria. <CHEM> wherein A represents hydrogen or OA represents N[(C10-C11) aliphatic acyl]-beta-D-2-deoxy-2-amino-glucopyranosyl, M represents hydrogen or OM represents alpha-D-manno-pyranosyl, with the proviso that when M represents hydrogen also A must represent hydrogen, and the addition salts thereof. w

Drugs covered by this patent

Patent Metadata

Patent number
EP0290922B1
Jurisdiction
EP
Classification
—
Expires
1993-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Gruppo Lepetit SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.